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New Help for Diagnosing Autoimmune Blistering Diseases 
Because the symptoms of the various autoimmune blistering dis-
eases often resemble one anoeher , the conditions can be hard to 
diagnose accurately. In this issue. however. three groups report 
resules that further define the immunological and pathological de-
fects of the skin lesions of epidermolysis hullosa acquisita (EBA), 
bullolls pemphigoid, and adult linear IgA dermatosis. The new in-
formation should provide improved cri teria for diagnosing these 
condi tions. 
In their studies of EBA. J o-David Fine of the University of Ala-
b:una :u Birmingham and Stephen Tyring and W. Ray Gammon of 
the Universi ty of North Carolina in Chapel Hill made an unex-
pected observation concerning the nature of the skin lesions in 
patients with this disease. "We began to notice that in the majotity 
of skin specimens taken early on, the blisters occur higher up in the 
basement membrane zone in the lamina lucida than previous work 
had indicated," Fine says. The skin separation was supposed to occur 
in the lamina dCllsa, where the aucoantibodies that apparendy trig-
ger the les ion formation are deposited. 
13lister location had been o ne of the cri teria used to distinguish 
EllA and bullous pemphigoid. In bullous pemphigoid, both the 
autoantibody deposition and skin separation occur in the lamina 
lucida. The finding by Fine, Tyring, and Gammon that skin separa-
tion in the lamina lucida can also occur in EllA lesions means that 
the lesion ultrastructure is not sufficiem to differenri:ae herween 
EBA and bullous pemphigoid. The two diseases can be distin-
guished. Fine says. by using direct immunoelectron microscopy to 
locate the antibodies within the skin lesions o r by determining 
whether the antibodies that the patients have in their blood react 
with EBA or bullous pemphigoid antigens. 
Fine, Tyring, and Gammon note that all of the EBA lesions that 
showed separation in the lamina lucida came from patients in the 
eady stages of che disease, within the first few months of symptom 
development. These lesions also characteristically concaincd invad-
ing neurrophils. The investigators suggest the lamina lucida may be 
particularly susceptible to the protein-digesting enzymes released 
by the neutrophils, thereby causing the skin to separate at that level. 
With further progression of the disease and more extensive skin 
damage, however, the lower levels of the skin can also be affected. 
Other investigators may not have found blistering within the lam-
ina lucida because they principally studied patiems with morc ad-
vanced cases of EBA. 
Meanwhile, Stephan Mueller, Vera Klaus-Kovtun. and John 
Stanley of the National Cancer Institu te (NCt) in Bethesda. Mary-
land, have confirmed th:u a particular constituen t of the basement 
membrane, a protein with a molecular weight of 230,000, is the 
major bullous pemphigoid antigen. This protein had been impli-
cated as a target for the autoantibodies that elicit the bullous pem-
phigoid lesions, but a number of studies had indicated that other 
3migens might also be involved. 
The NCI workers have now shown that 36 of 37 bullous pem-
phigoid patients have antibodies to the 230-kilodalton protein. 
"The vast majority are developing an autoantibody to the same 
protein," Sta nley says. Some have autoantibodies to other antigens 
as well, but the near uniform presence of antibodies to the 230-lciJo-
dalton protein means that it can be used in a diagnostic test for 
identifying bullous pemphigoid patients. 
Moreover. the work shows that the 230-kilodalton protein is a 
previously uncharacterized normal constituent of the basement 
membrane. The antibodies that react with it can be used to isolate 
the protein, thereby enabling researchers to get a better handle on 
basement membrane structure and function. 
Finally, the au toimmune blistering disease ca lled linear IgA der-
matosis has been mainly defined by the presence oflinear deposits of 
antibodies of the immunoglobulin A (lgA) type in the skin lesions. 
More commonly, blistering disease lesions contain deposits of im-
munoglobulin G (lgG) antibodies or of a component of the comple-
ment system. There has been some question about whether IgA 
deposition is characteristic of a unique disease or is simply an un-
usual feature of one or more or rhe other blistering diseases, espe-
cially since some of the patients with IgA deposits have IgG deposits 
as well. 
A group of researchers, led by Catherine Prost of the Hopital 
Henri Mondor in Creceil, France, now report that IgA deposits 
often form an unusual pattern not seen with other autoimmune 
deposits. In a study of 61 patients with subepidermal blistering 
diseases, the French workers identified 16 with IgA deposics. In 11 
of the t 6. the IgA was arrayed in a linear pattern. forming a mirror 
image above and below the lamina densa. Although the lesions of 4 
of the I t patients also contained IgG. the mirror-image pattern was 
never seen in patients who had only IgG or complement deposition. 
Prost and her colleagues suggest that the pattern may provide the 
first specific criterion for distinguishing linear IgA dermatOsis from 
other blistering diseases. 
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T Cells That Respond to Poison Ivy Have Been Isolated 
Several immune mechanisms have been implicated in rhe develop-
ment of delayed hypersensitivity reactions, such as that causing the 
contact dermatitis of poison ivy. "The big question," says Richard 
Kalish of the University of Minnesota School of Medicine in Min-
neapolis. "is which ofthese mechanisms are truly relevant [0 COIl-
tact dermatitis." In this issue, Kalish and Chikao Morimoto of 
Dana-Farber Cancer Institute in Boston report a development that 
should help to answer this question. The researchers have. for the 
first time. been ab le to isolate human T-cell clones that respond 
specifically [0 urushiol, the active ingredient of poison ivy plants. 
The T cells of the immune system playa key role in deteccing and 
responding to foreign antigens. Isolating the urushiol-specific T-
cells will simplify the study of the immune system's response to 
poison ivy by allowing rhe investigations to be carried out in vitro, 
which has been difficult to do before now. 
Kalish and Morimoto isolated the urushiol-specific T-cell clones 
from an individual who had had a case of poison ivy some 11 
months before. When the researchers characterized the clones, they 
were somewhat surprised to find that all of the T cells carried a 
surface molecule, known as COB, that marks them as members of 
the killer class of T cells. T cells that respond [0 other contact 
allergens, such as nickel, have been isolated and have generally 
belonged [0 [he helper. rather [han [he killer. T-cell class. 
Killer cells, as their name suggests, kill other cdls that bear some 
foreign antigen, whereas helper cells are needed to activate the B 
cells of the immune sysrem [0 produce antibodies to many antigens. 
Both types of T cell could be expected to contribute to rhe contact 
dermatitis of poison ivy, and it was therefore unexpected that only 
urushiol-specific killer cells were isolated. "They are probably not 
representative of what is bappening in the skin lesions," Kalish says, 
noting that the T cells were not isolated until many months after the 
lesions had cleared. 
In fact, some of the clone T cells behaved as suppressors of anti-
body production in response to poison ivy antigen. This finding 
suggests that rhe cells may be involved in rerminaring the immune 
reaction to the antigen, rather than producing it. Nevertheless, the 
methods developed by Kalish and Morimoto for isolating the T-cell 
clones can now be applied to cells in the lesions themselves, thereby 
providing the means to develop a clearer picture of the immune 
mechanisms that cause rhe contact dermatitis. 
